GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jianmin Pharmaceutical Group Co Ltd (SHSE:600976) » Definitions » EV-to-FCF

Jianmin Pharmaceutical Group Co (SHSE:600976) EV-to-FCF : 44.56 (As of Apr. 22, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Jianmin Pharmaceutical Group Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Jianmin Pharmaceutical Group Co's Enterprise Value is ¥6,113 Mil. Jianmin Pharmaceutical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was ¥137 Mil. Therefore, Jianmin Pharmaceutical Group Co's EV-to-FCF for today is 44.56.

The historical rank and industry rank for Jianmin Pharmaceutical Group Co's EV-to-FCF or its related term are showing as below:

SHSE:600976' s EV-to-FCF Range Over the Past 10 Years
Min: -1314.84   Med: 51.98   Max: 703.38
Current: 44.56

During the past 13 years, the highest EV-to-FCF of Jianmin Pharmaceutical Group Co was 703.38. The lowest was -1314.84. And the median was 51.98.

SHSE:600976's EV-to-FCF is ranked worse than
76.37% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.31 vs SHSE:600976: 44.56

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-22), Jianmin Pharmaceutical Group Co's stock price is ¥45.73. Jianmin Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥2.460. Therefore, Jianmin Pharmaceutical Group Co's PE Ratio (TTM) for today is 18.59.


Jianmin Pharmaceutical Group Co EV-to-FCF Historical Data

The historical data trend for Jianmin Pharmaceutical Group Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jianmin Pharmaceutical Group Co EV-to-FCF Chart

Jianmin Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.83 59.13 46.11 44.80 47.97

Jianmin Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.68 45.61 77.11 47.97 42.80

Competitive Comparison of Jianmin Pharmaceutical Group Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Jianmin Pharmaceutical Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jianmin Pharmaceutical Group Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jianmin Pharmaceutical Group Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Jianmin Pharmaceutical Group Co's EV-to-FCF falls into.


;
;

Jianmin Pharmaceutical Group Co EV-to-FCF Calculation

Jianmin Pharmaceutical Group Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6113.039/137.19
=44.56

Jianmin Pharmaceutical Group Co's current Enterprise Value is ¥6,113 Mil.
Jianmin Pharmaceutical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥137 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jianmin Pharmaceutical Group Co  (SHSE:600976) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Jianmin Pharmaceutical Group Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=45.73/2.460
=18.59

Jianmin Pharmaceutical Group Co's share price for today is ¥45.73.
Jianmin Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.460.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Jianmin Pharmaceutical Group Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Jianmin Pharmaceutical Group Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Jianmin Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
Executives
Du Ming De Director
He Qin Director
Gao Kai senior management
Wang Jun senior management
Huang Zhi Jun senior management
Pei Xue Jun senior management
Bu Zhong Jiang Director
Cheng Chao Yang senior management
Xu Sheng senior management
Hu Zhen Bo senior management
Liu Qin Qiang Director
Xiong Fu Liang senior management
Liu Peng senior management

Jianmin Pharmaceutical Group Co Headlines

No Headlines